Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57445

1.

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.

Nordström T, Vickers A, Assel M, Lilja H, Grönberg H, Eklund M.

Eur Urol. 2014 Aug 20. pii: S0302-2838(14)00752-0. doi: 10.1016/j.eururo.2014.08.010. [Epub ahead of print]

PMID:
25151013
[PubMed - as supplied by publisher]
2.

Significance of atypical small acinar proliferation and extensive high-grade prostatic intraepithelial neoplasm in clinical practice.

Adamczyk P, Wolski Z, Butkiewicz R, Nussbeutel J, Drewa T.

Cent European J Urol. 2014;67(2):136-41. doi: 10.5173/ceju.2014.02.art4. Epub 2014 Jun 23.

PMID:
25140226
[PubMed]
Free PMC Article
3.

Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.

Balbontin FG, Moreno SA, Bley E, Chacon R, Silva A, Morgentaler A.

BJU Int. 2014 Jul;114(1):125-30.

PMID:
25101359
[PubMed - indexed for MEDLINE]
4.

Expected population impacts of discontinued prostate-specific antigen screening.

Gulati R, Tsodikov A, Etzioni R, Hunter-Merrill RA, Gore JL, Mariotto AB, Cooperberg MR.

Cancer. 2014 Jul 25. doi: 10.1002/cncr.28932. [Epub ahead of print]

PMID:
25065910
[PubMed - as supplied by publisher]
5.

Gastric adenocarcinoma with prostatic metastasis.

Roshni S, Anoop T, Preethi T, Shubanshu G, Lijeesh A.

J Gastric Cancer. 2014 Jun;14(2):135-7. doi: 10.5230/jgc.2014.14.2.135. Epub 2014 Jun 30.

PMID:
25061542
[PubMed]
Free PMC Article
6.

Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis.

Pettersson H, Knutsen H, Holmberg E, Andréasson B.

Eur J Haematol. 2014 Jul 5. doi: 10.1111/ejh.12410. [Epub ahead of print]

PMID:
25039361
[PubMed - as supplied by publisher]
7.

Sudden loss of vision due to breast cancer metastasis to the eyeball.

Antosz ZS, Walocha J, Poręba R, Sioma-Markowska U.

Neuro Endocrinol Lett. 2014;35(4):249-51.

PMID:
25038605
[PubMed - in process]
8.

Association of the serum vascular endothelial growth factor levels with benign prostate hyperplasia and prostate malignancies.

Sharif MR, Shaabani A, Mahmoudi H, Nikoueinejad H, Akbari H, Einollahi B.

Nephrourol Mon. 2014 Apr 27;6(3):e14778. doi: 10.5812/numonthly.14778. eCollection 2014 May.

PMID:
25032132
[PubMed]
Free PMC Article
9.

NCCN endorses PSA testing in absence of better alternatives.

Reinke T.

Manag Care. 2014 May;23(5):39-41. No abstract available.

PMID:
25019148
[PubMed - indexed for MEDLINE]
Free Article
10.

Serum lactate dehydrogenase in combination with free-to-total serum prostate specific antigen ratio for diagnosis of prostate cancer.

Santotoribio JD, Cañavate-Solano C, Garcia-de la Torre A, Arce-Matute F, Perez-Ramos S.

Clin Lab. 2014;60(6):1055-8.

PMID:
25016713
[PubMed - indexed for MEDLINE]
11.

The bifunctional role of steroid hormones: implications for therapy in prostate cancer.

Mathew P.

Oncology (Williston Park). 2014 May;28(5):397-404. Review.

PMID:
25004653
[PubMed - indexed for MEDLINE]
12.

If you have an active vagus nerve, cancer stage may no longer be important.

Gidron Y, De Couck M, De Greve J.

J Biol Regul Homeost Agents. 2014 Apr-Jun;28(2):195-201.

PMID:
25001652
[PubMed - indexed for MEDLINE]
13.

New practice-changing study findings presented at ASCO.

O'Rourke K.

JAMA. 2014 Jul 16;312(3):218-9. No abstract available.

PMID:
24989114
[PubMed - indexed for MEDLINE]
14.

Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.

Kolostova K, Broul M, Schraml J, Cegan M, Matkowski R, Fiutowski M, Bobek V.

Anticancer Res. 2014 Jul;34(7):3641-6.

PMID:
24982381
[PubMed - indexed for MEDLINE]
15.

Heat-shock protein HSPB1 attenuates microRNA miR-1 expression thereby restoring oncogenic pathways in prostate cancer cells.

Stope MB, Stender C, Schubert T, Peters S, Weiss M, Ziegler P, Zimmermann U, Walther R, Burchardt M.

Anticancer Res. 2014 Jul;34(7):3475-80.

PMID:
24982356
[PubMed - indexed for MEDLINE]
16.

Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.

Park HS, Hong SK, Oh MM, Yoon CY, Jeong SJ, Byun SS, Cheon J, Lee SE, Moon du G.

Anticancer Res. 2014 Jul;34(7):3457-68.

PMID:
24982354
[PubMed - indexed for MEDLINE]
17.

Isolation of prostate cancer-related exosomes.

Mizutani K, Terazawa R, Kameyama K, Kato T, Horie K, Tsuchiya T, Seike K, Ehara H, Fujita Y, Kawakami K, Ito M, Deguchi T.

Anticancer Res. 2014 Jul;34(7):3419-23.

PMID:
24982349
[PubMed - indexed for MEDLINE]
18.

Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.

Huang H, Cui XX, Chen S, Goodin S, Liu Y, He Y, Li D, Wang H, Van Doren J, Dipaola RS, Conney AH, Zheng X.

Anticancer Res. 2014 Jul;34(7):3357-63.

PMID:
24982340
[PubMed - indexed for MEDLINE]
19.

Attacking an epidemic.

May M.

Sci Am. 2014 Jul;311(1):S4-5. No abstract available.

PMID:
24974698
[PubMed - indexed for MEDLINE]
20.

Introduction of transperineal image-guided prostate brachytherapy.

Aronowitz JN.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):907-15. doi: 10.1016/j.ijrobp.2014.04.010. Review.

PMID:
24969799
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk